Advertisement
Screener

Alkermes plc. (ALKS) Due to Employees, Current

2.8 / 5 stars · 68/120 Roast Me

Alkermes plc. Due to Employees, Current

Alkermes plc. (ALKS) had Due to Employees, Current of $51.54 million as of 2020-03-31, per its 10-Q filed 2020-04-29.

Discontinued › Notes

us-gaap:DueToEmployeesCurrent · last filed 2020-04-29

  • 2020-03-31: Due to Employees, Current $51.54M.
  • 2019-12-31: Due to Employees, Current $72.07M.
  • 2019-09-30: Due to Employees, Current $69.19M.
  • 2019-06-30: Due to Employees, Current $54.01M.
Period endDue to Employees, Current
2020-03-31$51.54M
10-Q · filed 2020-04-29
2019-12-31$72.07M
10-Q · filed 2020-04-29
2019-09-30$69.19M
10-Q · filed 2019-10-23
2019-06-30$54.01M
10-Q · filed 2019-07-25
2019-03-31$48.65M
10-Q · filed 2019-04-25
2018-12-31$67.61M
10-K · filed 2020-02-13
2018-09-30$60.47M
10-Q · filed 2018-10-23
2018-06-30$43.93M
10-Q · filed 2018-07-26
2018-03-31$46.97M
10-Q · filed 2018-04-26
2017-12-31$54.57M
10-K · filed 2019-02-15
2017-09-30$48.23M
10-Q · filed 2017-10-26
2017-06-30$37.28M
10-Q · filed 2017-07-27
2017-03-31$32.59M
10-Q · filed 2017-04-27
2016-12-31$45.62M
10-K · filed 2018-02-16
2016-09-30$38.49M
10-Q · filed 2016-11-02
2016-06-30$37.22M
10-Q · filed 2016-07-28
2016-03-31$24.05M
10-Q · filed 2016-04-28
2015-12-31$40.37M
10-K · filed 2017-02-17
2015-09-30$33.87M
10-Q · filed 2015-10-29
2015-06-30$29.11M
10-Q · filed 2015-07-30
2015-03-31$18.35M
10-Q · filed 2015-04-30
2014-12-31$36.85M
10-K · filed 2016-02-25
2014-09-30$25.12M
10-Q · filed 2014-10-29
2014-06-30$23.20M
10-Q · filed 2014-07-31
2014-03-31$14.21M
10-Q · filed 2014-04-30
2013-12-31$28.10M
10-K · filed 2015-02-24
2013-09-30$17.73M
10-Q · filed 2013-10-31
2013-06-30$15.39M
10-Q · filed 2013-07-25
2013-03-31$30.43M
10-KT · filed 2014-02-27
2012-12-31$23.00M
10-Q · filed 2013-01-31
2012-09-30$13.99M
10-Q · filed 2012-11-01
2012-06-30$13.33M
10-Q · filed 2012-07-26
2012-03-31$25.02M
10-K · filed 2013-05-23
2011-03-31$17.48M
10-K · filed 2012-05-18

Similar stocks

Stock NameCountryMarket CapPE Ratio
RHYTHM PHARMACEUTICALS, INC. (RYTM)United States$6.771B-37.20
IONIS PHARMACEUTICALS INC (IONS)United States$7.277B-23.25
Liquidia Corp (LQDA)United States$6.347B51.23
Amneal Pharmaceuticals, Inc. (AMRX)$6.326B25.62
Spyre Therapeutics, Inc. (SYRE)United States$7.685B-43.69
Structure Therapeutics Inc. (GPCR)United States$7.710B-53.41
Praxis Precision Medicines, Inc. (PRAX)United States$7.884B-27.60
Mirum Pharmaceuticals, Inc. (MIRM)United States$5.798B-8.81
Travere Therapeutics, Inc. (TVTX)United States$5.712B-123.10
Oruka Therapeutics, Inc. (ORKA)United States$5.663B-43.76